Table 2.

Univariate analysis before vs. after comparisons for NAC and AC

Type of perioperative chemotherapy administered	2000–2007 (n=168)	2008–2012 (n=110)	p value
NAC, n (%)	13 (7.7)	29 (26.4)	<0.001
No. receiving NAC/year, median (range)	1.5 (0–3)	4 (2–10)
% receiving NAC/year, median (range)	8.2 (0.0–15.8)	22.2 (9.1–47.6)
AC, n (%)	57 (33.9)	17 (15.4)	<0.001
No. receiving AC/year, median (range)	7 (3–10)	3 (1–6)
%receiving AC/year, median (range)	32.7 (15.8–62.5)	14.3 (4.2–33.3)

Use of NAC increased while use of AC decreased after the initiation of the MDBCC.

AC: adjuvant chemotherapy; MDBCC: multidisciplinary bladder cancer clinic; NAC: neoadjuvant chemotherapy.